Screening Of Diabetes In PregnancyBarış Sever, Halil Gursoy Pala
Izmir University of Health Sciences, Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, Division of Perinatology
INTRODUCTION: The prevalence of gestational diabetes mellitus (GDM) is approximately 6 percent of pregnant women in the United States. The prevalence ranges from about 2% to 38% worldwide and varies among racial-ethnic groups, often paralleling the prevalence of type 2 diabetes. The prevalence also varies due to differences in screening practices, population characteristics (eg, mean age and body mass index [BMI] of pregnant women), testing method, and diagnostic criteria. Keywords: Gestational diabetes, diabetes screening tests, oral glucose tolerance test
METHODS: The prevalence is increasing over time, possibly due to increases in mean maternal age and weight, particularly with increasing obesity. In 2010, the International Association of Diabetes and Pregnancy Study Groups proposed new screening and diagnostic criteria for diabetes in pregnancy. Using these criteria, the global prevalence of hyperglycemia in pregnancy is estimated at 17 percent, with regional estimates ranging from 10 percent in North America to 25 percent in Southeast Asia.
RESULTS: Different screening programs are carried out in different clinics, and all these differences lead to different results in the frequency of GDM. Which method and which threshold value will be accepted depends on the health policies of the countries, the experience of the clinicians and the characteristics of the patient population.
DISCUSSION AND CONCLUSION: In this review, we analyzed the methods recommended for GDM screening in pregnancy.
Corresponding Author: Barış Sever, Türkiye